Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BostonGene

< Previous 1 2 3 Next >
News headline image
BostonGene CCO Dr. Ferran Prat to Moderate External Innovation Panel at Longwood Healthcare Leaders Boston CEO Conference
From BostonGene
Via Business Wire
News headline image
BostonGene and Medical University of South Carolina Announce Strategic Collaboration to Advance CAR-T Therapy Insights for Lymphoma and Leukemia
From BostonGene
Via Business Wire
News headline image
BostonGene Showcases Biologically Grounded AI at ESMO Congress 2026 to Advance Drug Development and Precision Clinical Decision-Making
From BostonGene
Via Business Wire
News headline image
BostonGene and Kyoto University Establish Strategic Partnership to Advance Biomarker Discovery for Combination Immunotherapy
From BostonGene
Via Business Wire
News headline image
BostonGene Named “Overall AI-based Analytics Company of the Year” in 2026 AI Breakthrough Awards Program
From BostonGene
Via Business Wire
News headline image
BostonGene to Feature Next-Generation AI Foundation Models for Precision Immuno-Oncology at the 22nd Annual RadMed Symposium
From BostonGene
Via Business Wire
News headline image
BostonGene Receives Diamond Pinnacle Award for AI-Driven Decision-Making in Oncology Drug Prediction
From BostonGene
Via Business Wire
News headline image
BostonGene to Present High-Impact AI Models and Biomarker-Driven Frameworks at EHA2026 Congress
From BostonGene
Via Business Wire
News headline image
BostonGene to Demonstrate Power of AI Models in Tumor and Immune Biology at the 2026 ASCO® Annual Meeting
From BostonGene
Via Business Wire
News headline image
BostonGene and ImmunoGenesis Announce Strategic Partnership to Overcome Immunotherapy Resistance
From BostonGene
Via Business Wire
News headline image
BostonGene to Present 13 Abstracts at the American Association for Cancer Research Annual Meeting 2026 Showcasing AI-Platform for Drug Development
From BostonGene
Via Business Wire
News headline image
BostonGene to Highlight the Role of AI Foundation Models in Optimizing Cancer Immunotherapy at Precision Medicine World Conference 2026
From BostonGene
Via Business Wire
News headline image
BostonGene Named “Overall Immunology Company of the Year” by BioTech Breakthrough for Its AI-Driven Platform That Transforms Immuno-Oncology Drug Development Through Advanced Biomarker Discovery, Real-Time Monitoring, and Precision Patient Selection
From BostonGene
Via Business Wire
News headline image
BostonGene to Present Seven Studies Unveiling Novel AI-Driven Breast Cancer Breakthroughs at SABCS 2025
From BostonGene
Via Business Wire
News headline image
BostonGene to Showcase Transformative Impact of AI-Driven Profiling with Six Abstracts at the 67th American Society of Hematology Annual Meeting & Exposition
From BostonGene
Via Business Wire
News headline image
BostonGene and Kyoto University Partner to Accelerate Precision Drug Development
From BostonGene
Via Business Wire
News headline image
BostonGene to Present Omnimodal Foundation AI for Cancer and the Immune System at SITC 2025 Annual Meeting
From BostonGene
Via Business Wire
News headline image
BostonGene to Highlight Omnimodal AI Innovations for Precision Oncology at the 21st Annual Precision Oncology & RadMed Symposium
From BostonGene
Via Business Wire
News headline image
BostonGene Honored with Five 2025 Stevie® Awards for Technology Excellence
From BostonGene
Via Business Wire
News headline image
BostonGene Showcases AI-Powered Multimodal Analytics at ESMO Congress 2025 to Advance Cancer Research and Drug Development
From BostonGene
Via Business Wire
News headline image
BostonGene Named Platinum Winner for AI Research Innovation at 2025 Pinnacle Awards
From BostonGene
Via Business Wire
News headline image
BostonGene to Participate in the 2025 IASLC World Conference on Lung Cancer
From BostonGene
Via Business Wire
News headline image
BostonGene Publishes Landmark Study Providing Clinical and Analytical Validation for Its Multimodal RNA and DNA Assay
From BostonGene
Via Business Wire
News headline image
BostonGene Named “AI-based Drug Discovery Solution of the Year” in 2025 AI Breakthrough Awards Program
From BostonGene
Via Business Wire
News headline image
BostonGene Announces Collaboration with SWOG Cancer Research Network to Drive Personalized Approaches
From BostonGene
Via Business Wire
News headline image
BostonGene to Present AI-Powered Solutions Advancing Patient-Centric Drug Development at The Festival of Genomics & Biodata Boston 2025
From BostonGene
Via Business Wire
News headline image
BostonGene’s Multiomic AI Platform Uncovers Therapeutic Targets in Invasive Lobular Carcinoma, Wins GRASP Advocate Choice Award at ASCO 2025
From BostonGene
Via Business Wire
News headline image
BostonGene Announces Participation at the American Association for Cancer Research Annual Meeting 2025
From BostonGene
Via Business Wire
News headline image
BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer
From BostonGene
Via Business Wire
News headline image
BostonGene to Participate in the 114th Annual Meeting of the United States and Canadian Academy of Pathology
From BostonGene
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.